These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24955377)

  • 1. Autoantibody response to murine double minute 2 protein in immunodiagnosis of hepatocellular carcinoma.
    Liu M; Zheng SJ; Chen Y; Li N; Ren PF; Dai LP; Duan ZP; Zhang JY
    J Immunol Res; 2014; 2014():906532. PubMed ID: 24955377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral autoimmune response to nucleophosmin in the immunodiagnosis of hepatocellular carcinoma.
    Liu M; Varela-Ramirez A; Li J; Dai L; Aguilera RJ; Zhang JY
    Oncol Rep; 2015 May; 33(5):2245-52. PubMed ID: 25779011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cancer-related protein 14-3-3ζ is a potential tumor-associated antigen in immunodiagnosis of hepatocellular carcinoma.
    Liu M; Liu X; Ren P; Li J; Chai Y; Zheng SJ; Chen Y; Duan ZP; Li N; Zhang JY
    Tumour Biol; 2014 May; 35(5):4247-56. PubMed ID: 24390614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies against glucose-regulated protein 78 as serological diagnostic biomarkers in hepatocellular carcinoma.
    Shao Q; Ren P; Li Y; Peng B; Dai L; Lei N; Yao W; Zhao G; Li L; Zhang J
    Int J Oncol; 2012 Sep; 41(3):1061-7. PubMed ID: 22692946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-associated autoantibodies are useful biomarkers in immunodiagnosis of α-fetoprotein-negative hepatocellular carcinoma.
    Wang T; Liu M; Zheng SJ; Bian DD; Zhang JY; Yao J; Zheng QF; Shi AM; Li WH; Li L; Chen Y; Wang JH; Duan ZP; Dong L
    World J Gastroenterol; 2017 May; 23(19):3496-3504. PubMed ID: 28596685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibody response to Sui1 and its tissue-specific expression in hepatocellular carcinoma.
    Zhou JW; Li Y; Yue LX; Luo CL; Chen Y; Zhang JY
    Tumour Biol; 2016 Feb; 37(2):2547-53. PubMed ID: 26386724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined use of murine double minute-2 promoter methylation and serum AFP improves diagnostic efficiency in hepatitis B virus-related hepatocellular carcinoma.
    Wang JW; Qian Y; Wu CS; Zhao NH; Fang Y; Yuan XD; Gao S; Fan YC; Wang K
    Int J Med Sci; 2020; 17(18):3190-3199. PubMed ID: 33173438
    [No Abstract]   [Full Text] [Related]  

  • 8. Autoantibodies against glucose-regulated protein 78 as serological biomarkers in metastatic and recurrent hepatocellular carcinoma.
    Ying X; Han SX; He CC; Zhou CY; Dong YP; Cai MJ; Sui X; Ma CX; Sun X; Zhang YY; Gou WL; Mason C; Zhu Q
    Oncotarget; 2017 Apr; 8(15):24828-24839. PubMed ID: 28186997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of Ra1A and its tissue-specific expression in hepatocellular carcinoma.
    Wang K; Chen Y; Liu S; Qiu S; Gao S; Huang X; Zhang J; Peng X; Qiani W; Zhang JY
    Int J Immunopathol Pharmacol; 2009; 22(3):735-43. PubMed ID: 19822090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel immunodiagnosis panel for hepatocellular carcinoma based on bioinformatics and the autoantibody-antigen system.
    Wu J; Wang P; Han Z; Li T; Yi C; Qiu C; Yang Q; Sun G; Dai L; Shi J; Wang K; Ye H
    Cancer Sci; 2022 Feb; 113(2):411-422. PubMed ID: 34821436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using immunomic approach to enhance tumor-associated autoantibody detection in diagnosis of hepatocellular carcinoma.
    Dai L; Ren P; Liu M; Imai H; Tan EM; Zhang JY
    Clin Immunol; 2014; 152(1-2):127-39. PubMed ID: 24667685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-testis antigen GAGE-1 expression and serum immunoreactivity in hepatocellular carcinoma.
    Chao NX; Li LZ; Luo GR; Zhong WG; Huang RS; Fan R; Zhao FL
    Niger J Clin Pract; 2018 Oct; 21(10):1361-1367. PubMed ID: 30297572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma.
    Zhang JY; Megliorino R; Peng XX; Tan EM; Chen Y; Chan EK
    J Hepatol; 2007 Jan; 46(1):107-14. PubMed ID: 17067715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of anti-SF3B1 autoantibody as a diagnostic marker in patients with hepatocellular carcinoma.
    Hwang HM; Heo CK; Lee HJ; Kwak SS; Lim WH; Yoo JS; Yu DY; Lim KJ; Kim JY; Cho EW
    J Transl Med; 2018 Jun; 16(1):177. PubMed ID: 29954402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum anti-osteopontin autoantibody as a novel diagnostic and prognostic biomarker in patients with hepatocellular carcinoma.
    Ying X; Zhao Y; Wang JL; Zhou X; Zhao J; He CC; Guo XJ; Jin GH; Wang LJ; Zhu Q; Han SX
    Oncol Rep; 2014 Oct; 32(4):1550-6. PubMed ID: 25109745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum anti-EIF3A autoantibody as a potential diagnostic marker for hepatocellular carcinoma.
    Heo CK; Hwang HM; Lee HJ; Kwak SS; Yoo JS; Yu DY; Lim KJ; Lee S; Cho EW
    Sci Rep; 2019 Jul; 9(1):11059. PubMed ID: 31363116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum DHCR24 Auto-antibody as a new Biomarker for Progression of Hepatitis C.
    Ezzikouri S; Kimura K; Sunagozaka H; Kaneko S; Inoue K; Nishimura T; Hishima T; Kohara M; Tsukiyama-Kohara K
    EBioMedicine; 2015 Jun; 2(6):604-12. PubMed ID: 26288822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum autoantibody measurement for the detection of hepatocellular carcinoma.
    Middleton CH; Irving W; Robertson JF; Murray A; Parsy-Kowalska CB; Macdonald IK; McElveen J; Allen J; Healey GF; Thomson BJ; Ryder SJ; Holdenrieder S; Chapman CJ
    PLoS One; 2014; 9(8):e103867. PubMed ID: 25093332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies response to MDM2 and p53 in the immunodiagnosis of esophageal squamous cell carcinoma.
    Chai Y; Peng B; Dai L; Qian W; Zhang Y; Zhang JY
    Scand J Immunol; 2014 Nov; 80(5):362-8. PubMed ID: 24965442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum anti-Ku86: a potential biomarker for early detection of hepatocellular carcinoma].
    Chu L; Zhang X; Wang G; Zhou W; Du Z; Liu A; Zhao H
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):123-7. PubMed ID: 24796461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.